4//SEC Filing
Androski Lindsay 4
Accession 0001104659-25-006782
CIK 0001035354other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:35 PM ET
Size
7.7 KB
Accession
0001104659-25-006782
Insider Transaction Report
Form 4
Androski Lindsay
Director
Transactions
- Exercise/Conversion
Common Stock
2025-01-24+3,750→ 15,750 total - Exercise/Conversion
Restricted Stock Units
2025-01-24−3,750→ 3,750 total→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001936604
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 5:35 PM ET
- Size
- 7.7 KB